Evidence-based management of bullous pemphigoid.

Published

Journal Article (Review)

Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease typically affecting the elderly. Although different therapeutic regimens have been proposed, a review of the evidence is needed to aid clinicians in their decision making and management. Systemic therapies such as corticosteroids and adjuvants are effective in BP but are plagued with adverse effects, and potent topical steroids are an alternative treatment. This article reviews the evidence supporting different therapeutic options in the management of BP.

Full Text

Duke Authors

Cited Authors

  • Daniel, BS; Borradori, L; Hall, RP; Murrell, DF

Published Date

  • October 2011

Published In

Volume / Issue

  • 29 / 4

Start / End Page

  • 613 - 620

PubMed ID

  • 21925006

Pubmed Central ID

  • 21925006

Electronic International Standard Serial Number (EISSN)

  • 1558-0520

Digital Object Identifier (DOI)

  • 10.1016/j.det.2011.06.003

Language

  • eng

Conference Location

  • United States